METHOTREXATE 5mg. IP

The disease-modifying antirheumatic drug of choice for the management of rheumatoid arthritis worldwide. (Michael H Schiff, 2014) A remarkable drug with a key role in the management of rheumatoid arthritis. (Peter. C. Taylor, 2019) Displays good overall efficacy for signs and symptoms, inhibition of structural damage, and preservation of function in rheumatoid arthritis patients. (Peter. C. Taylor, 2019) A well-recognized therapy for many inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, and psoriasis. (Hans H. Herfarth, 2016) The most effective and commonly used medicines to treat various forms of arthritis and other rheumatic conditions. (Juergen Braun, 2009) Slows down the body's immune system and helps reduce inflammation, and prevents joint stiffness. An effective therapeutic drug for inflammatory arthritis in patients who do not respond to therapy with nonsteroidal anti-inflammatory drugs or slow-acting antirheumatic drugs. (L E Boh, 1986) Prevents further permanent damage that can happen if rheumatoid arthritis is not treated. (Maria Angeles Lopez‐Olivo, 2014) Shows significant reduction in duration of morning stiffness, and a number of tender or painful joints in patients with severe rheumatoid arthritis refractory. (A M Boerbooms, 1988) An effective agent in the short-term treatment for patients with rheumatoid arthritis, refractory to hydroxychloroquine, aurothioglucose, D-penicillamine, and azathioprine. (A M Boerbooms, 1988) An effective, well-tolerable, and safe medication for patients with rheumatoid arthritis. (B F Leeb, 1996)